Moxetumomab pasudotox-tdfk Intravenous and Soma Compound with Codeine
Determining the interaction of Moxetumomab pasudotox-tdfk Intravenous and Soma Compound with Codeine and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab pasudotox, Moxetumomab Pasudotox
Generic Name: aspirin / carisoprodol / codeine
Brand name: Soma Compound with Codeine
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Moxetumomab pasudotox-tdfk Intravenous-Somatropin
- Moxetumomab pasudotox-tdfk Intravenous-Somatropin (rDNA origin - Nonrefrigerated) (SBS)
- Moxetumomab pasudotox-tdfk Intravenous-Somatropin (rDNA origin)
- Moxetumomab pasudotox-tdfk Intravenous-Somatropin for Weight Gain
- Moxetumomab pasudotox-tdfk Intravenous-Somatropin, e-coli derived Subcutaneous, Injection
- Moxetumomab pasudotox-tdfk Intravenous-Somatropin, mammalian derived Subcutaneous, Injection
- Soma Compound with Codeine-Moxifloxacin
- Soma Compound with Codeine-Moxifloxacin (Systemic)
- Soma Compound with Codeine-Moxifloxacin Hydrochloride
- Soma Compound with Codeine-Moxifloxacin Injection
- Soma Compound with Codeine-Moxifloxacin Intravenous
- Soma Compound with Codeine-Moxifloxacin Tablets